Using a combination of cytochrome P450 1B1 and β-catenin for early diagnosis and prevention of colorectal cancer

Cancer Detection and Prevention

Volumn 29, Issue 6, 2005, Pages 562-569

  Chang, Han ^a,b   Su, Jang Ming ^b   Huang, Chee C ^b   Liu, Lan C ^b   Tsai, Chung H ^b   Chou, Ming Chih ^b   Lin, Pinpin ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Adenomas; AhR; Aryl hydrocarbon receptor; bcl 2 expression; beta catenin; Colorectal cancer; Colorectum; Combined diagnostic test; CYP1B1; Cytochrome P450; Diagnosis; Differentiation; Dysplasia; Early diagnosis; Lymph node metastasis; p53; Prevention

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; BETA CATENIN; BIOLOGICAL MARKER; CYTOCHROME P450 1B1; NUCLEAR PROTEIN; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ARTICLE; CALCULATION; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER SCREENING; CARCINOGENESIS; COLON; COLON TUMOR; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; DISEASE ASSOCIATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION; VALIDATION PROCESS;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; COLONIC NEOPLASMS; EARLY DIAGNOSIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ARYL HYDROCARBON; SENSITIVITY AND SPECIFICITY; STEROID 11-BETA-HYDROXYLASE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 28744436727     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2005.09.007     Document Type: Article

References (47)

1. C.C. Boring, T.S. Squires, T. Tong, and S. Montgomery Cancer statistics CA Cancer J Clin 44 1994 7 26
2. E.R. Fearon, and B. Vogelstein A genetic model for colorectal tumorigenesis Cell 61 1990 759 767
3. B. Vogelstein, E.R. Fearon, and S.R. Hamilton Genetic alterations during colorectal-tumor development N Engl J Med 319 1988 525 532
4. S.J. Winawer, A.G. Zauber, and M.N. Ho Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup N Engl J Med 329 1993 1977 1981
5. D.F. Ransohoff, and C.A. Lang Screening for colorectal cancer with the fecal occult blood test: a background paper. American College of Physicians Ann Intern Med 126 1997 811 822
6. S. Subramanian, M. Klosterman, M.M. Amonkar, and T.L. Hunt Adherence with colorectal cancer screening guidelines: a review Prev Med 38 2004 536 550
7. S. Bosari, L. Moneghini, and D. Graziani Bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas, and adenocarcinomas Hum Pathol 26 1995 534 540
8. A. Kikuchi Tumor formation by genetic mutations in the components of the Wnt signaling pathway Cancer Sci 94 2003 225 229
9. A.J. Levine p53, the cellular gatekeeper for growth and division Cell 88 1997 323 331
10. H.A. Saleh, H. Jackson, G. Khatib, and M. Banerjee Correlation of bcl-2 oncoprotein immunohistochemical expression with proliferation index and histopathologic parameters in colorectal neoplasia Pathol Oncol Res 5 1999 273 279
11. T. Ito, K. Kaneko, and R. Makino Clinical significance in molecular detection of p53 mutation in serum of patients with colorectal carcinoma Oncol Rep 10 2003 1937 1942
12. I. Kiss, J. Sandor, G. Pajkos, B. Bogner, G. Hegedus, and I. Ember Colorectal cancer risk in relation to genetic polymorphism of cytochrome P450 1A1, 2E1, and glutathione-S-transferase M1 enzymes Anticancer Res 20 2000 519 522
13. F. Guengerich, and T. Shimada Activation of procarcinogens by human cytochrome P450 enzymes Mutat Res 400 1998 201 213
14. G.I. Murray, M.C. Taylor, and M.C. McFadyen Tumor-specific expression of cytochrome P450 CYP1B1 Cancer Res 57 1997 3026 3031
15. P. Lin, H. Chang, W. Ho, M. Wu, and J. Su Association of aryl hydrocarbon receptor and cytochrome P4501B1 expressions in human non-small cell lung cancers Lung Cancer 42 2003 255 261
16. M.H. Aziz, R. Kumar, and N. Ahmad Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review) Int J Oncol 23 2003 17 28
17. C.O. Leong, M. Gaskell, and E.A. Martin Antitumour 2-(4-aminophenyl) benzothiazoles generate DNA adducts in sensitive tumour cells in vitro and in vivo Br J Cancer 88 2003 470 477
18. M.C. McFadyen, W.T. Melvin, and G.I. Murray Cytochrome P450 enzymes: novel options for cancer therapeutics Mol Cancer Ther 3 2004 363 371
19. T. Shimada, C.L. Hayes, and H. Yamazaki Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1 Cancer Res 56 1996 2979 2984
20. S.E. Shehin, R.O. Stephenson, and W.F. Greenlee Transcriptional regulation of the human CYP1B1 gene. Evidence for involvement of an aryl hydrocarbon receptor response element in constitutive expression J Biol Chem 275 2000 6770 6776
21. J. Hakkola, M. Pasanen, and O. Pelkonen Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells Carcinogenesis 18 1997 391 397
22. L. Muskhelishvili, P.A. Thompson, D.F. Kusewitt, C. Wang, and F.F. Kadlubar In situ hybridization and immunohistochemical analysis of cytochrome P450 1B1 expression in human normal tissues J Histochem Cytochem 49 2001 229 236
23. P. Gibson, J.H. Gill, and P.A. Khan Cytochrome P450 1B1 (CYP1B1) is overexpressed in human colon adenocarcinomas relative to normal colon: implications for drug development Mol Cancer Ther 2 2003 527 534
24. S. Hamilton, and L. Aaltonen Carcinoma of the colon and rectum S. Hamilton L. Aaltonen World health organization classification of tumors. Pathology and genetics of tumors of the digestive system 2000 IARC Press Lyon 103 147
25. F.L. Greene, D.L. Page, and I.D. Fleming Colon and rectum, in AJCC cancer staging manual 2002 Springer New York p. 113-30
26. M. Kashani, G. Steiner, and A. Haitel Expression of the aryl hydrocarbon receptor (AhR) and the aryl hydrocarbon receptor nuclear translocator (ARNT) in fetal, benign hyperplastic, and malignant prostate Prostate 37 1998 98 108
27. K. Polyak, S.R. Hamilton, B. Vogelstein, and K.W. Kinzler Early alteration of cell-cycle-regulated gene expression in colorectal neoplasia Am J Pathol 149 1996 381 387
28. J. Jen, S.M. Powell, and N. Papadopoulos Molecular determinants of dysplasia in colorectal lesions Cancer Res 54 1994 5523 5526
29. M. Beard Predictors of performance on national board examinations. Part II J Dent Educ 48 1984 458 462
30. G.A. Kramer, and D.R. DeMarais Reliability and validity of the pilot National Board Dental Examination J Dent Educ 56 1992 236 241
31. E. Stip, and A. Mancini-Marie Cognitive function and depression in symptom resolution in schizophrenia patients treated with an atypical antipsychotic Brain Cogn 55 2004 463 465
32. J. Wen, M.-Q. Gao, Z.-W. Lin, and G.-X. Yang Quantitative study of multiple biomarkers of colorectal tumor with diagnostic discrimination model World J Gastroenterol 10 2004 439 442
33. M. Kumarakulasingham, P.H. Rooney, and S.R. Dundas Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis Clin Cancer Res 11 2005 3758 3765
34. Y. Schneider, F. Vincent, and B. Duranton Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells Cancer Lett 158 2000 85 91
35. J. Lu, C.H. Ho, G. Ghai, and K.Y. Chen Resveratrol analog 3,4,5,4′-tetrahydroxystilbene, differentially induces pro-apoptotic p53/Bax gene expression and inhibits the growth of transformed cells but not their normal counterparts Carcinogenesis 22 2001 321 328
36. G.A. Potter, L.H. Patterson, and E. Wanogho The cancer preventive agent resveratrol is converted to the anticancer agent piceatannol by cytochrome P450 enzyme CYP1B1 Br J Cancer 86 2002 774 778
37. D.A. Ahlquist, J.E. Skoletsky, and K.A. Boynton Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel Gastroenterology 119 2000 1219 1227
38. B. Levin, and J.H. Bond Colorectal cancer screening: recommendations of the U.S. Preventive Services Task Force. American Gastroenterological Association Gastroenterology 111 1996 1381 1384
39. J. Martinez, C. Afshari, P. Bushel, A. Masuda, T. Takahashi, and N. Walker Differential toxicogenomic responses to 2,3,7,8,-tetrachlorodibenzo-p- dioxin in malignant and nonmalignant human airway epithelial cells Toxicol Sci 69 2002 409 423
40. M.F. Wu, W.J. Wu, and G.C. Chang Increased expression of cytochrome P4501B1 in peripheral leukocytes from lung cancer patients Toxicol Lett 150 2004 211 219
41. S. Kanaoka, K. Yoshida, N. Miura, H. Sugimura, and M. Kajimura Potential usefulness of detecting cyclooxygenase 2 messenger RNA in feces for colorectal cancer screening Gastroenterology 127 2004 422 427
42. C.C. Chan, S. Boyce, and C. Brideau Rofecoxib [Vioxx MK-0966; 4-(4′-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles J Pharmacol Exp Ther 290 1999 551 560
43. T. Higuchi, T. Iwama, K. Yoshinaga, M. Toyooka, M.M. Taketo, and K. Sugihara A randomized, double-blind, placebo-controlled trial of the effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients Clin Cancer Res 9 2003 4756 4760
44. J.K. Kerzee, and K.S. Ramos Constitutive and inducible expression of Cyp1a1 and Cyp1b1 in vascular smooth muscle cells: role of the Ahr bHLH/PAS transcription factor Circ Res 89 2001 573 582
45. B.C. Spink, M.M. Hussain, B.H. Katz, L. Eisele, and D.C. Spink Transient induction of cytochromes P450 1A1 and 1B1 in MCF-7 human breast cancer cells by indirubin Biochem Pharmacol 66 2003 2313 2321
46. W. Zheng, P.B. Brake, K.K. Bhattacharyya, L. Zhang, D. Zhao, and C.R. Jefcoate Cell selective cAMP induction of rat CYP1B1 in adrenal and testis cells. Identification of a novel cAMP-responsive far upstream enhancer and a second Ah receptor-dependent mechanism Arch Biochem Biophys 416 2003 53 67
47. J. Guo, M. Sartor, and S. Karyala Expression of genes in the TGF-beta signaling pathway is significantly deregulated in smooth muscle cells from aorta of aryl hydrocarbon receptor knockout mice Toxicol Appl Pharmacol 194 2004 79 89